Christopher D. Roberts, Chief Scientific Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 2,500 shares at $25.54 ($64K) on 2021-04-05, disclosed to the SEC on 2021-04-07.
Open-market sale of $64k BDTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BDTX | SELL | 2021-02-04 | $63K | — | Filing → |
| BDTX | SELL | 2021-01-06 | $140K | — | Filing → |
| BDTX | SELL | 2020-12-04 | $81K | — | Filing → |